GCM
BNTX icon

Ghisallo Capital Management’s BioNTech BNTX Stock Holding History

Ghisallo Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-125,000
Closed -$12.3M – 213
2025
Q3 		$12.3M Buy
+125,000
New +$13.4M 0.4% 51

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ghisallo Capital Management's BNTX Position: Q4 2025 in Review

Ghisallo Capital Management sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 125,000 shares — an estimated $12.3M sold.

Ghisallo Capital Management first reported a position in BNTX in Q3 2025 and held it in 1 quarter. The position peaked at $12.3M in Q3 2025. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • Ghisallo Capital Management reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • Ghisallo Capital Management sold 125,000 BioNTech shares in Q4 2025, an estimated $12.3M.
  • Ghisallo Capital Management first reported a position in BioNTech in Q3 2025 and held it in 1 quarter.
  • Ghisallo Capital Management's BioNTech position peaked at $12.3M in Q3 2025.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Ghisallo Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.